Vivek Mishra (Fibroheal)
Overview
Vivek Mishra is a renowned Indian entrepreneur and the Founder and CEO of Fibroheal Woundcare Pvt Ltd, a company specializing in the utilization of silk proteins as biomaterials for advanced wound care management. Founded in 2017, Fibroheal is recognized for its innovative approach to using silk-based products for medical applications, particularly in wound healing. Under Vivek's leadership, the company has developed several revolutionary products like silk protein-based bandages and ointments that enhance scarless healing. Fibroheal's innovations have gained national recognition, supported by government funds and are active in more than 500 hospitals across India.
Recent Developments
In recent years, Fibroheal Woundcare has experienced significant milestones and growth under Vivek Mishra’s leadership:
- December 2024: The company raised INR 6.3 crore in a Pre-Series A funding round aimed at scaling its market strategy and expanding its workforce.
- November 2023: Vivek Mishra was featured in the Karnataka State Department of IT, BT & ST's award recognition as one of the state's best startups.
- February 2023: Fibroheal was recognized in a national scientific magazine for its silk fibroin-based dressing, reflecting its commitment to leveraging local resources for global healthcare solutions.
- 2023: Vivek Mishra was a distinguished speaker at the TEDxMAHE Bengaluru event, discussing innovation and entrepreneurship in biotechnology.
- 2022-2024: The company received multiple rounds of funding from KITVEN, the venture arm of the Karnataka government, highlighting the strategic importance and trust in Fibroheal’s initiatives.
Personal Information
| Attribute | Information |
|---|---|
| Full Name | Vivek Mishra |
| Born | Not publicly available |
| Nationality | Indian |
| Occupation | Entrepreneur, CEO of Fibroheal |
| Known For | Innovating silk protein applications in healthcare |
| Education | MBA, University of Pune; B. Pharma, BPUT |
Early Life and Education
Vivek Mishra was born in India, and although specific details of his early life are not widely publicized, it is known that he pursued his higher education in pharmaceutical sciences and business. He earned a Bachelor's degree from Biju Patnaik University of Technology and went on to complete his MBA at the University of Pune. This educational background provided him with a strong foundation in both technical and business disciplines, setting the stage for his future entrepreneurial endeavors.
Career and Notable Achievements
Vivek Mishra's professional journey began with stints in significant roles across the healthcare and pharmaceutical industries. His interest in biomaterials and entrepreneurial spirit led to the founding of Fibroheal Woundcare in 2017.
- 2017: Founded Fibroheal Woundcare, focusing on silk protein-based medical solutions.
- 2019: Successfully patented multiple silk protein-based products.
- 2020: Received National Technology Award for innovation in medical textile applications.
- 2022: Expanded product reach to over 500 hospitals across 19 Indian states.
- 2023: Presented at several international forums highlighting sustainable medical innovations.
Current Work and Impact
Vivek Mishra currently leads Fibroheal Woundcare in its mission to revolutionize wound care through silk-based products. Under his guidance, the company has developed a robust line of advanced wound care products such as D-Fibroheal Scarlite and other silk-based ointments and bandages. His focus is on reducing India's dependency on imported wound care products, offering cost-effective and efficient local solutions.
Fibroheal Powder
Fibroheal Woundcare’s product line includes the innovative Fibroheal Powder, a silk protein-derived formulation designed to promote faster healing in diabetic foot ulcers, infected wounds, and surgical sites. The unique properties of silk proteins aid in quicker wound closure and significantly reduce treatment costs, offering both economic and clinical advantages.
Fibroheal Ointment
Another notable product is the Fibroheal Ointment, recognized for its advanced wound healing properties through the application of bio-compatible silk protein. This ointment is especially beneficial in reducing scarring and has contributed significantly to improving patients’ quality of life post-healing.
Conclusion
Vivek Mishra has made a significant impact in the field of biotechnology and healthcare in India through his leadership at Fibroheal Woundcare. His work on silk protein applications not only highlights a unique approach to wound care but also aligns with broader economic goals such as reducing import reliance and enhancing local innovation. With continued advancements and the potential for international expansion, Fibroheal is poised to influence global medical practices through sustainable and cost-effective solutions.